OnKure Therapeutics's market cap is currently $35.18M. The company's EPS TTM is $-1.19; its P/E ratio is ―; OnKure Therapeutics is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
